ECM
AMPH icon

Everence Capital Management’s Amphastar Pharmaceuticals AMPH Stock Holding History

Everence Capital Management’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-6,470
Closed -$314K – 830
2024
Q3 		$314K Hold
6,470
– – 0.02% 568
2024
Q2 		$267 Hold
6,470
– – 0.02% 574
2024
Q1 		$284 Hold
6,470
– – 0.02% 583
2023
Q4 		$400K Hold
6,470
– – 0.03% 468
2023
Q3 		$298 Hold
6,470
– – 0.02% 552
2023
Q2 		$287K Hold
6,470
– – 0.02% 537
2023
Q1 		$243 Buy
+6,470
New +$212K 0.02% 615

Other funds holding AMPH

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $34.9B AUM 18.19% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return